Abiopharma

(30% Negative) EyePoint, Inc. (EYPT) Announces Delay in Conference Trials for San Francisco on Tuesday Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

CareDx - CareDx and 10x Genomics to LaunchImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response

(99% Neutral) GENPREX, INC. (GNPX) Files Form 8-K

Evogene and Unravel Biosciences Announce Collaboration to Develop a First-in-Class Therapy to Reverse Neurological Damage in Demyelinating Disorders

Novo Nordisk International Operations Commits to Veeva Vault CRM

New Form 15-12G - Clearside Biomedical, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-005412 Size: 11 KB

KAMADA (KMDA) Files Form 6-K

Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism

Gain Therapeutics Announces Conference Participation During J.P. Morgan Healthcare Conference Week

Viking Therapeutics Announces Appointment of Neil Aubuchon as Chief Commercial Officer

Syndax and World Orphan Drug Alliance to Launch a Multi-Regional Managed Access Program, Expanding Access to Revuforj® (revumenib) Outside the U.S.

Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones

BioXcel Therapeutics Planning to Submit sNDA This Month Seeking FDA Approval for At-Home Use of IGALMI®